Details for Patent: 11,571,531
✉ Email this page to a colleague
Which drugs does patent 11,571,531 protect, and when does it expire?
Patent 11,571,531 protects ONZETRA XSAIL and is included in one NDA.
This patent has twenty patent family members in seven countries.
Drugs Protected by US Patent 11,571,531
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | 11,571,531 | ⤷ Subscribe | METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,571,531
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2006217724 | ⤷ Subscribe | |||
Canada | 2598953 | ⤷ Subscribe | |||
Canada | 2918226 | ⤷ Subscribe | |||
China | 101217992 | ⤷ Subscribe | |||
China | 103463716 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |